Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Bagirath Gangadharan, PhD, Birgit Reipert, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karin Fijn van Draat, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, Margaret V. Ragni, MD MPH, Hassan M. Yaish, MD, Amy D. Shapiro, MD, Donald L Yee, MD, Vlad Calin Radulescu, MD, Elena Santagostino, Deborah Brown, MD

Blood (2017) 130 (Supplement 1): 88.

https://doi.org/10.1182/blood.V130.Suppl_1.88.88

Published: 2017

Journal Articles

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

Birgit M Reipert, PhD, Bagirath Gangadharan, PhD, Christoph J Hofbauer, PhD, Fritz Scheiflinger, PhD, Joel Bowen, Elizabeth Donnachie, PhD, Karen Fijvandraat, MD, Ralph A. Gruppo, MD, Jenny Klintman, MD PhD, Christoph Male, MD, Catherine E. McGuinn, MD, Shannon L. Meeks, MD, Michael Recht, MD PhD, M V Ragni, MD, Hassan M Yaish, Elena Santagostino, MD PhD, Deborah L Brown, MD

Blood (2016) 128 (22): 328.

https://doi.org/10.1182/blood.V128.22.328.328

Published: 2016

Journal Articles

A “Biomedical Analytics” Approach Suggests a Role For TNF Superfamily Signaling In Acquired Hemophilia Patients Who Do Not Respond To Rituximab Treatment

Keri Csencsits Smith, PhD, Mary F McGuire, PhD, Elizabeth Donnachie, PhD, Miguel Antonio Escobar, MD

Blood (2013) 122 (21): 3592.

https://doi.org/10.1182/blood.V122.21.3592.3592

Published: 2013

Journal Articles

Recombinant Factor VIIa Partially Reverses the Effects of Anticoagulants and Antiplatelet Agents on Thrombin Generation and Thromboelastography.

Mariam L. Abdullatif, Elizabeth Donnachie, PhD, Miguel Escobar, MD

Blood (2005) 106 (11): 4143.

https://doi.org/10.1182/blood.V106.11.4143.4143

Published: 2005

Journal Articles

Irreversible Blockade of Factor VIII Antibodies.

Stephanie Planque, MS, Miguel A. Escobar, MD, Hiroaki Taguchi, PhD, Sangeeta Karle, MS, Yasuhiro Nishiyama, PhD, Elizabeth Donnachie, PhD, Sudhir Paul, PhD

Blood (2004) 104 (11): 1728.

https://doi.org/10.1182/blood.V104.11.1728.1728

Published: 2004

NARROW

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

A “Biomedical Analytics” Approach Suggests a Role For TNF Superfamily Signaling In Acquired Hemophilia Patients Who Do Not Respond To Rituximab Treatment

Recombinant Factor VIIa Partially Reverses the Effects of Anticoagulants and Antiplatelet Agents on Thrombin Generation and Thromboelastography.

Irreversible Blockade of Factor VIII Antibodies.

Email alerts

ASH Publications

American Society of Hematology

Longitudinal Antibody Signatures Following FVIII Replacement Therapy in Previously Untreated Patients with Severe Hemophilia Α- New Insights from the Hemophilia Inhibitor PUP Study (HIPS)

Appearance of High-Affinity Antibodies Precedes Clinical Diagnosis of FVIII Inhibitors - Preliminary Analysis from the Hemophilia Inhibitor PUP Study (HIPS)

A “Biomedical Analytics” Approach Suggests a Role For TNF Superfamily Signaling In Acquired Hemophilia Patients Who Do Not Respond To Rituximab Treatment

Recombinant Factor VIIa Partially Reverses the Effects of Anticoagulants and Antiplatelet Agents on Thrombin Generation and Thromboelastography.

Irreversible Blockade of Factor VIII Antibodies.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only